A  Golden Angels Investors

http://www.goldenangelsinvestors.com





     Office Locations:

250 N. Sunnyslope Rd., Suite 245
Brookfield, WI 53005
Phone: 262-439-4421
Fax: 262-364-2311

 

Stages:

  • Early
  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    The mission of The Golden Angels Network is to provide a forum in which its members can exchange information about investment opportunities in early-stage technology and emerging growth companies in Wisconsin and Illinois. The Golden Angels Network was formed at Marquette University in early 2003. Its members provide early-stage capital in the range of $250,000 - $1,250,000, an investment range not generally served by venture capital funds. Since 2003, it has invested over $10 million. Today the network considers business opportunities primarily from Illinois and Wisconsin, as well as from other Midwestern states. The group has over 60 members, about half of whom are alumni of Marquette University.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Tim Keane Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/31/2017


      Promentis Pharmaceuticals


      WI


      $26,000,000


      Series C


     

    Portfolio companies include:


      Akoya
        web link


      AquaMOST
        web link


      Cellectar


      Concert Hot Spot
        web link


      Flex Biomedical
        web link


      OpGen
        web link


      PerBlue
        web link


      Promentis Pharmaceuticals
        web link


      Ratio


      Vital Sensors
        web link


     

    Recent News: